000 01863 a2200541 4500
005 20250515211922.0
264 0 _c20100920
008 201009s 0 0 eng d
022 _a1533-4023
024 7 _a10.1097/FJC.0b013e3181d9f5f4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYen, Chia-Hung
245 0 0 _aSildenafil limits monocrotaline-induced pulmonary hypertension in rats through suppression of pulmonary vascular remodeling.
_h[electronic resource]
260 _bJournal of cardiovascular pharmacology
_cJun 2010
300 _a574-84 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aArterioles
_xdrug effects
650 0 4 _aBlood Vessels
_xmetabolism
650 0 4 _aCaspase 3
_xmetabolism
650 0 4 _aConnexin 43
_xmetabolism
650 0 4 _aHypertension
_xmetabolism
650 0 4 _aHypertension, Pulmonary
_xchemically induced
650 0 4 _aLung
_xblood supply
650 0 4 _aMale
650 0 4 _aMonocrotaline
_xadverse effects
650 0 4 _aNitric Oxide Synthase Type III
_xmetabolism
650 0 4 _aPiperazines
650 0 4 _aPurines
650 0 4 _aRandom Allocation
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSildenafil Citrate
650 0 4 _aSulfones
650 0 4 _aTumor Necrosis Factor-alpha
_xadverse effects
650 0 4 _aVentricular Myosins
_xadverse effects
700 1 _aLeu, Steve
700 1 _aLin, Yu-Chun
700 1 _aKao, Ying-Hsien
700 1 _aChang, Li-Teh
700 1 _aChua, Sarah
700 1 _aFu, Morgan
700 1 _aWu, Chiung-Jen
700 1 _aSun, Cheuk-Kwan
700 1 _aYip, Hon-Kan
773 0 _tJournal of cardiovascular pharmacology
_gvol. 55
_gno. 6
_gp. 574-84
856 4 0 _uhttps://doi.org/10.1097/FJC.0b013e3181d9f5f4
_zAvailable from publisher's website
999 _c19590711
_d19590711